Repligen | RGEN - 债务利息支出



金融业
股票价格
USD
资产
USD 2.95B
现金及等价物
USD 606.78M
销售成本
USD 94.09M
流动资产
USD 1.2B
流动负债
USD 132.66M
债务
USD 690.94M
EBIT
USD 21.13M
EBITDA
USD 43.77M
员工
1.78K
EPS每股收益
USD 0.54
股本和储备
USD 2.11B
销售毛利
USD 110.04M
债务利息支出
USD 5.66M
利息收入
USD 7.31M
贷款资金
USD 551.05M
市值
USD 9.27B
净收入
USD 5.01M
营业费用
USD 183M
营业利润
USD 21.13M
普通股股本
USD 56.43M
PE价格收益
105.09
税前利润
USD 14.15M
销售收入
USD 204M
销售和管理费用
USD 76.62M
股票
USD 186.6M
贸易债权人
USD 33.23M
应收帐款人
USD 157.71M


债务利息支出 更改 日
Agilent USD 25M 0 2026-03
Align Technology USD 6.93M 9.11M 2026-03
Bio Techne USD 3.6M 1.19M 2026-06
BioMarin Pharmaceutical USD 63.29M 48.34M 2026-06
Bristol-Myers Squibb USD 407M 4M 2026-06
Bruker USD 17.8M 9.7M 2026-06
Charles River Laboratories USD 30.34M 3.6M 2026-06
Danaher USD 107M 44M 2026-06
Dentsply International USD 22M 2M 2026-06
General Electric Aerospace USD 496M 271M 2025-12
Henry Schein USD 43M 4M 2026-06
Illumina USD 24M 2M 2026-03
IQVIA Holdings USD 197M 5M 2026-06
Mettler Toledo International USD 17.25M 239K 2026-06
Myriad Genetics USD 4.4M 600K 2025-12
OraSure Technologies 1.67M 1.13M 2025-12
Pacific Biosciences Of California USD 1.74M 1000 2025-12
Pfizer USD 667M 4M 2026-06
Repligen USD 5.66M 85K 2026-06
Revvity USD 22.99M 1.73M 2026-06
Standard Biotools USD 5K 5K 2025-12
Thermo Fisher Scientific USD 354M 11M 2026-03
Waters USD 55M 13M 2026-06
West Pharmaceutical Services USD 1.9M 1.7M 2026-03